Study of Efficacy and Safety of GR1501 in Patients with Radiographic Axial Spondyloarthritis

NCT05881785 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

465

Enrollment

INDUSTRY

Sponsor class

Conditions

Axial Spondyloarthritis

Interventions

BIOLOGICAL: GR1501 low dose
BIOLOGICAL: GR1501 high dose
BIOLOGICAL: placebo

Sponsor

Genrix (Shanghai) Biopharmaceutical Co., Ltd.